Showing results (2021-2030 of 2,046) with videos related to
Sort By:
Pageof 205
Biorxiv : the Preprint Server for Biology|April 8, 2025
Glutamate indicators with increased sensitivity and tailored deactivation ratesAbhi Aggarwal, Adrian Negrean, Yang Chen, et al.Cancer Research|February 18, 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular CarcinomaRenée L Flaherty, Flavia Hughes, George Sflomos, et al.Cancer Discovery|June 14, 2020
Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with BRCA1/2- and Non-BRCA1/2-Mutant CancersTimothy A Yap, Rebecca Kristeleit, Vasiliki Michalarea, et al.Nature Communications|April 14, 2015
Logging cuts the functional importance of invertebrates in tropical rainforestRobert M Ewers, Michael J W Boyle, Rosalind A Gleave, et al.Nature Communications|September 7, 2022
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancerMarta Palafox, Laia Monserrat, Meritxell Bellet, et al.Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|May 17, 2016
Concerted Uranium Research in Europe (CURE): toward a collaborative project integrating dosimetry, epidemiology and radiobiology to study the effects of occupational uranium exposureOlivier Laurent, Maria Gomolka, Richard Haylock, et al.The New England Journal of Medicine|September 29, 2021
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19David M Weinreich, Sumathi Sivapalasingam, Thomas Norton, et al.The New England Journal of Medicine|August 4, 2021
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19Meagan P O'Brien, Eduardo Forleo-Neto, Bret J Musser, et al.Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Subcutaneous REGEN-COV Antibody Combination for Covid-19 PreventionMeagan P O'Brien, Eduardo Forleo-Neto, Bret J Musser, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2025
Clinical challenges and proposed solutions for patients with invasive lobular breast cancerK Van Baelen, E Sawyer, J Van Cauwenberge, et al.Pageof 205